458,300 Shares in American Vanguard Corporation $AVD Acquired by Potomac Capital Management Inc.

Potomac Capital Management Inc. acquired a new position in shares of American Vanguard Corporation (NYSE:AVD) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 458,300 shares of the basic materials company’s stock, valued at approximately $1,751,000. American Vanguard comprises about 1.4% of Potomac Capital Management Inc.’s investment portfolio, making the stock its 20th largest holding. Potomac Capital Management Inc. owned 1.61% of American Vanguard as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Essex Investment Management Co. LLC acquired a new position in shares of American Vanguard during the 3rd quarter worth approximately $2,136,000. Cove Street Capital LLC raised its position in shares of American Vanguard by 12.1% during the 3rd quarter. Cove Street Capital LLC now owns 1,398,986 shares of the basic materials company’s stock worth $8,030,000 after purchasing an additional 150,703 shares during the last quarter. EVR Research LP raised its position in shares of American Vanguard by 136.5% during the 3rd quarter. EVR Research LP now owns 340,000 shares of the basic materials company’s stock worth $1,952,000 after purchasing an additional 196,216 shares during the last quarter. Legato Capital Management LLC acquired a new position in shares of American Vanguard during the 3rd quarter worth approximately $697,000. Finally, Bridgeway Capital Management LLC raised its position in shares of American Vanguard by 60.5% during the 3rd quarter. Bridgeway Capital Management LLC now owns 100,706 shares of the basic materials company’s stock worth $578,000 after purchasing an additional 37,953 shares during the last quarter. 79.00% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, May 18th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, American Vanguard currently has a consensus rating of “Sell”.

American Vanguard Trading Up 12.2%

Shares of AVD opened at $2.99 on Wednesday. The stock has a fifty day moving average of $2.70 and a two-hundred day moving average of $3.73. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.41 and a current ratio of 2.32. The company has a market capitalization of $85.40 million, a PE ratio of -1.88 and a beta of 1.43. American Vanguard Corporation has a fifty-two week low of $2.05 and a fifty-two week high of $5.92.

American Vanguard (NYSE:AVD) last issued its quarterly earnings results on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.08). The business had revenue of $123.57 million during the quarter, compared to analyst estimates of $120.00 million. American Vanguard had a negative net margin of 8.71% and a negative return on equity of 4.13%.

Insiders Place Their Bets

In other American Vanguard news, Director Patrick E. Gottschalk purchased 25,000 shares of the business’s stock in a transaction on Tuesday, May 19th. The stock was bought at an average cost of $2.70 per share, for a total transaction of $67,500.00. Following the acquisition, the director owned 191,705 shares of the company’s stock, valued at approximately $517,603.50. The trade was a 15.00% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 5.60% of the company’s stock.

American Vanguard Company Profile

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.